CTRI/2023/08/056905招募中4 期
A prospective, single-arm, multicenter, observationalsafety surveillance study of VyndaMx® (Tafamidiscapsule 61 mg) in patients with Transthyretin amyloidcardiomyopathy (ATTR-CM) in India - NI
Pfizer Products India Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adult patients aged 18 years and more with diagnosis of cardiomyopathy of wild type or hereditary transthyretin mediated amyloidosis and Patients to whom VyndaMx Capsules is prescribed for the treatment of ATTR-CM.
排除标准
- •Patient with hypersensitivity to VyndaMx® Capsule or to any of the excipients in the product
- •Patients with rare hereditary problems of fructose intolerance.
- •Patient who has a contraindication to VyndaMx® Capsules according to the approved local product label.
研究者
相似试验
招募中
4 期
Post Marketinng Surveillance to Evaluate implant survivorship and performance of the Freedom® Total Knee System in Total Knee ArthroplastyCTRI/2016/11/007455Meril Life Sciences India Pvt Ltd400
尚未招募
4 期
MITSU AB™ absorbable poly (glycolide/L-lactide) surgical suture U.S.P withantibacterial triclosan coatingCTRI/2024/08/071764Meril Life Sciences Pvt Ltd
招募中
Unknown
OptimalCare StudyStable angina, Chronic coronary syndromes, Coronary artery diseaseD060050Stable anginaJPRN-jRCT1040230051Kinoshita Yoshihisa200
尚未招募
不适用
A prospective, single-arm, multicenter, investigator-initiated, interventional study to evaluate the efficacy and safety of switching from low- and moderate-intensity statin to Ezetimibe 10 mg and ROsuvastatIn 2.5 mg CombinAtion therapy in patients with type 2 diabetes mellitus with dyslipidemia. (EROICA)KCT0008224Hanyang University Guri Hospital665
招募中
不适用
Multicenter prospective cohort study to evaluate renal tubular function after switching from ETV to TAF - Niigata University study groupJPRN-UMIN000042929niigata university50